Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Thermo Fisher set to benefit from demand for testing kits, vaccines

Stock MarketsOct 26, 2021 01:41PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. FILE PHOTO: A scientist researcher, wearing protective gear, shows a box controlling the air quality in the lab at the Thermo Fisher plant, former Novasep, producing COVID-19 vaccines for AstraZeneca in Seneffe, Belgium, February 10, 2021. REUTERS/Yves H

By Amruta Khandekar and Mrinalika Roy

(Reuters) - Thermo Fisher Scientific Inc (NYSE:TMO)'s third-quarter profit is likely to get a boost from a rebound in COVID-19 testing due to the highly contagious Delta variant and sustained demand for vaccines against the coronavirus, Wall Street analysts said.

In July, when cases eased in the United States, the company cut its annual sales forecast for COVID-19 tests by $900 million. But the demand has again picked up pace in recent months amid a surge in Delta-led infections.

The world's largest maker of scientific instruments, which also supplies raw materials for COVID-19 vaccines and therapies, may see some benefit from the United States authorizing booster doses for some age-groups.

However, Thermo Fisher is unlikely to lift its testing forecast, according to Atlantic Equities analyst James Mainwaring, as it shifts its focus to its core business of making scientific instruments used in pharmaceutical and academic research.

The business took a hit last year as the pandemic disrupted research activities, but showed a strong recovery in the second quarter.


** Thermo Fisher's COVID-19 response revenue, which consists of supply for vaccines and therapies as well as testing kits, helped cushion the hit to its mainstay business from COVID-19 curbs and beat profit expectations for the past few quarters.

** Demand for test kits from employers in the United States have surged in the past few months and has even resulted in a supply crunch as the U.S. government mandated big employers to inoculate their workers and test them every week.

** Last week, rival Abbott Laboratories (NYSE:ABT) raised its 2021 profit forecast due to the recent uptick in testing demand. However, Quest Diagnostics (NYSE:DGX) warned of a slowdown in demand through the rest of the year as infections decline.


** Thermo Fisher is expected to report third-quarter revenue of $8.39 billion on Oct. 27, according to the mean estimate from 15 analysts, based on Refinitiv data

** Thermo Fisher reported overall second-quarter sales of $9.27 billion.

(GRAPHIC: Thermo Fisher overall revenue vs COVID-19 response revenue -


** The current average analyst rating on Thermo Fisher shares is "buy", with eight analysts rating it "strong buy", 12 "buy" and two "hold"

** Wall Street's median 12-month price target is $670

** The company's shares have risen about 30.5% so far this year



July. 3 2021 $5.44 $5.60 BEAT

April. 3 2021 $6.65 $7.21 BEAT

Dec. 31 2020 $6.56 $7.09 BEAT

Sept. 26 2020 $4.31 $5.63 BEAT

June. 27 2020 $3.42 $3.89 BEAT

March. 28 2020 $2.79 $2.94 BEAT

Thermo Fisher set to benefit from demand for testing kits, vaccines

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email